This site is intended for healthcare professionals only

Antidiabetes drugs

Filter:

The SCOUT study: A soap opera … the story so far
Potential benefit of early metformin combination therapy in T2D
Inpatient diabetes? There’s an app for that…
Management of diabetes during Ramadan: The potential of newer interventions
Update on combination GLP-1 receptor agonist and insulin therapy in the management of type 2 diabetes
Diabetes Distilled review of the year: Key topic 2
Diabetes Distilled review of the year: Key topic 1
Newer therapies in type 2 diabetes: An introduction to the latest glucose-lowering agents
A passport for diabetes in care setting: Improving the management of diabetes
Could a weight management pathway for people treated with GLP-1 receptor agonists improve self-management and metabolic outcomes?
Incretin-based diabetes therapies: An updated statement from the PCDS Committee
SGLT2 inhibitors – a novel approach to managing hyperglycaemia
Incretin-based diabetes therapies: Updated statement from the PCDS Committee
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.